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conducted. Most studies, including this study, have reported 
that robotic colorectal surgery is safe and feasible based on 
short-term outcomes [1-4]. Baek et al. [5], based on a three-
year follow-up, reported that robotic rectal surgery could be 
carried out safely in terms of recurrence and survival rates. 
However, all such studies are limited by small sample size and 
by the fact that they were conducted at a single institution. 
The short-term and the long-term outcomes of robotic colorec-
tal surgery will be verified based on these clinical studies and 
on any advantages of the new robotic system compared with 
the conventional laparoscopic system (fewer conversions, fewer 
complications, etc.), but the high cost for robotic systems and 
instruments still remains a problem for wide application. Thus, 
some additional studies that are quite different from laparo-
scopic clinical studies and that will study the merits of robotic 
surgery are needed. We still hunger for strong evidence regard-
ing the advantages to patients and surgeons that will outweigh 
the high cost of robotic systems and equipment. Recently, in a 
prospective comparative study of a laparoscopic and a robotic 
TME, the urogential function was recovered earlier in the ro-
botic TME than in the laparoscopic one [6]. Recently, the ro-
botic versus laparoscopic resection for rectal cancer trial, a pro-
spective randomized clinical trial comparing robotic-assisted 
and laparoscopic surgery for rectal cancer, was begun. In Korea, 
the COLRAR trial, a prospective, randomized, controlled trial 
of assess robotic-assisted surgery and laparoscopy assisted sur-
gery in patients with mild- or low rectal cancer, was also re-
cently begun. Even though a good landmark has not yet been 
found, we must be on the path to find such a landmark.
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Since a robotic system was first applied to colorectal cancer 
surgery at Severance Hospital in 2006, robotic surgery cases 
have increased rapidly, while 33 da Vinci robotic systems be-
ing installed at 27 hospitals and a total of 14,067 cases by the 
end of 2010 in Korea. Among the total cases, 6,365 cases (45%) 
were in the field of general surgery, such as thyroid, stomach 
and colorectal surgery. Compared with laparoscopic surgery, 
Surgery with robotic systems is known to have several advan-
tages, including a more ergonomic position, a stable camera 
platform, a stereoscopic view, elimination of tremors, and im-
proved dexterity. The author, an experienced laparoscopic 
colorectal surgeon, analyzed his personal initial experiences 
with robotic and laparoscopic colorectal surgery. He found 
more positive results in robotic surgery than in laparoscopic 
surgery even though the parameters did not show any statisti-
cally significance differences. For example, a lower conversion 
rate, less blood loss, more harvested lymph nodes and better 
short-term clinical outcomes were noted in robotic series How-
ever, no cost-benefit-analysis data were presented in this arti-
cle. These data are really in the same form as those in studies 
conducted during the initial period of laparoscopic surgery. 
The process of validating the feasibility and safety of robotic 
colorectal surgery seems to be following the same road map 
as that for laparoscopic surgery. 
Many papers have presented comparative studies between 
robotic colorectal surgery and open colorectal surgery. Large 
clinical prospective randomized clinical trials have also been 
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